Ezetimibe
Zetia
Dietary Cholesterol Absorption Inhibitor
NADAC/unit
$0.0725
No Shortage
Tier 1: 41.0%
12 Manufacturers
12 ANDAs
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyper....
vs. brand Zetia: Generic saves up to 99% per unit
Active Shortages
2025-06-27 A business decision was made to discontinue manufacture of the product, Actavis Pharma, Inc.
2025-06-27 A business decision was made to discontinue manufacture of the product, Actavis Pharma, Inc.
2025-06-27 A business decision was made to discontinue manufacture of the product, Actavis Pharma, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDAMNEAL PHARMACEUTICALS CO GMBHAUROBINDO PHARMA LTDGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT IIIOHM LABORATORIES INCORGANON LLC A SUB OF ORGANON AND COORIENT PHARMA CO LTDSANDOZ INCSCIEGEN PHARMACEUTICALS INCWATSON LABORATORIES INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.